Market research
TAKE.NSE TAKE Solutions Limited
NSE INR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- 26.0
- Analyst target
- 275
- Dividend yield
- Not available
- Beta
- 0.38
Profile
Instrument facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- INE142I01023
- Market cap
- 2B
- P/E ratio
- 26.0
- Analyst target
- 275
- Dividend yield
- Not available
- Beta
- 0.38
About
About TAKE Solutions Limited
TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and supply chain industries in India. The company offers intelligent platforms across life sciences, clinical research, biotechnology, and preventive healthcare. It also provides collaboration platform services, including subscription based software, implementation and configuration, maintenance and support, and other professional services. The company was formerly known as TAKE Solutions Limited and change its name to TAKE LIMITED in June 2026. TAKE LIMITED was incorporated in 2000 and is based in Chennai, India.
Research context
TAKE Solutions Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the TAKE.NSE discussion.
5 years, 6 months ago
TAKE Solutions Limited is currently in a long term uptrend where the price is trading 19.9% above its 200 day moving average.
From a valuation standpoint, the stock is 83.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
TAKE Solutions Limited's total revenue sank by 66.8% to $2B since the same quarter in the previous year.
Its net income has dropped by 150.5% to $-255M since the same quarter in the previous year.
Finally, its free cash flow grew by 51.3% to $775M since the same quarter in the previous year.
Based on the above factors, TAKE Solutions Limited gets an overall score of 3/5.